Application of CRISPR/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neurons by Uberbacher, C. et al.
Contents lists available at ScienceDirect
Stem Cell Research
journal homepage: www.elsevier.com/locate/scr
Application of CRISPR/Cas9 editing and digital droplet PCR in human iPSCs
to generate novel knock-in reporter lines to visualize dopaminergic neurons
Christa Überbachera,b,⁎,†, Julia Obergasteigera, Mattia Voltaa, Serena Veneziaa, Stefan Müllerc,
Isabella Pesced, Sara Pizzia, Giulia Lamonacaa, Anne Picarda, Giada Cattelana, Giorgio Malpelie,f,
Michele Zolib,g, Dayne Beccano-Kellyh,i, Rowan Flynnj, Richard Wade-Martinsh,i,
Peter P. Pramstallera, Andrew A. Hicksa, Sally A. Cowleyi,j,#, Corrado Cortia,#,⁎
a Institute for Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck, Bolzano, Italy
bDepartment of Biomedical, Metabolic and Neural Sciences, Università di Modena e Reggio Emilia, Modena, Italy
c Institute of Human Genetics, Munich University Hospital, Ludwig-Maximilians University, Munich, Germany
d CIBIO – Centre for Integrative Biology, Università degli Studi di Trento, Trento, Italy
e Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Section of Surgery, University of Verona, Verona, Italy
fDepartment of Diagnostics and Public Health, University of Verona, Verona, Italy
g Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy
hDepartment of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK
iOxford Parkinson's Disease Centre, University of Oxford, Oxford, UK
j James Martin Stem Cell Facility, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK
A R T I C L E I N F O
Keywords:
Human induced pluripotent stem cells
Dopaminergic neurons
CRISPR/Cas9
Knock-in, Digital droplet PCR, Fluorescent
reporter, FACS
A B S T R A C T
Human induced pluripotent stem cells (hiPSCs) have become indispensable for disease modelling. They are an
important resource to access patient cells harbouring disease-causing mutations. Derivation of midbrain
dopaminergic (DAergic) neurons from hiPSCs of PD patients represents the only option to model physiolo-
gical processes in a cell type that is not otherwise accessible from human patients. However, differentiation
does not produce a homogenous population of DA neurons and contaminant cell types may interfere with the
readout of the in vitro system. Here, we use CRISPR/Cas9 to generate novel knock-in reporter lines for DA
neurons, engineered with an endogenous fluorescent tyrosine hydroxylase – enhanced green fluorescent
protein (TH-eGFP) reporter. We present a reproducible knock-in strategy combined with a highly specific
homologous directed repair (HDR) screening approach using digital droplet PCR (ddPCR). The knock-in cell
lines that we created show a functioning fluorescent reporter system for DA neurons that are identifiable by
flow cytometry.
1. Introduction
Parkinson´s disease (PD) is the second most common neurodegen-
erative disorder after Alzheimer's disease, and the most common neu-
rodegenerative movement disorder (Nussbaum and Ellis 2003). It is
characterised by resting tremor, rigidity, bradykinesia and postural
instability. Symptoms of PD are associated with a profound loss of DA
neurons in the substantia nigra pars compacta (SNpc) resulting in de-
pletion of DA in the striatum and other projection areas. The details of
the selective vulnerability of the DA neurons to neurodegeneration in
PD are still unclear, despite several hypotheses having been proposed
throughout the years (Bolam and Pissadaki, 2012). Midbrain DA neu-
rons share the molecular marker protein tyrosine hydroxylase (TH), the
rate limiting enzyme in biosynthesis of DA (Nagatsu et al., 1964). TH is
commonly used as a marker to specifically identify DA neurons
(Chambers et al., 2009; Fedele et al., 2017; Kirkeby et al., 2012).
Human induced pluripotent stem cells (hiPSCs) are an important
resource for disease modelling of PD, especially because they are easily
accessible, can be derived from PD patients and efficiently differ-
entiated into functional DA neurons (Hartfield et al., 2014;
Kirkeby et al., 2012; Kriks et al., 2011). Efficiency of both hiPSC deri-
vation and the generation of DA neurons is variable from patient to
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patient and individual cell lines respectively. The most common ap-
proaches involve dual SMAD inhibition of cells cultivated either in a
monolayer (Kriks et al., 2011) or as embryoid bodies (Kirkeby et al.,
2012). There is, however, a lack of consistency in the literature on the
yields of TH positive cells obtained through these methods and gen-
erally, a heterogeneous population of neurons can be observed. Both
are important considerations to be taken into account when using this
cell model, as depending on the readout method, it is not possible to
exclude non-DA cells from analyses or to morphologically distinguish
them from other neuronal cell types. Different reporter systems for TH
have been described (Cui et al., 2016; Kelly et al., 2006) but only a
recent study has shown that a fluorescent reporter driven by an en-
dogenous promoter can faithfully mimic TH expression in vitro
(Xia et al., 2017). Previous reporters were, however, created in human
embryonic stem cells (hESCs) using transcription activator-like effector
nucleases (TALENs), a technology for which not all laboratories have
the capacities and expertise to produce.
Here, using a CRISPR/Cas9 genetic engineering approach, we report
the generation of novel knock-in cell lines that carry an endogenous
enhanced green fluorescent protein (eGFP) reporter for TH. We present
an easily reproducible approach for CRISPR/Cas9 gene editing of
hiPSCs, which we combined with a novel digital droplet PCR (ddPCR)
assay design as a highly specific screening method for homology di-
rected repair (HDR), thus facilitating the process. The ddPCR technique
is based on partitioning of DNA and PCR mix into nanoliter-sized oil
droplets, and allows absolute quantification of nucleic acids even of
very low abundance (Hindson et al., 2011). We demonstrate that
CRISPR/Cas9 allows a seamless knock-in and the production of reporter
cell lines that allow identification of TH-expressing cells by Fluorescent
– activated cell sorting (FACS).
2. Methods and materials
2.1. Cell lines
The genetic engineering was carried out on three hiPSC lines in
parallel, obtained from healthy donors. Namely:
- 802#7
- SFC856-03-04 (STBCi063-A)
- SFC840-03-05 (STBCi026-C)
Both SFC856-03-04 and SFC840-03-05 are cell lines from the
StemBANCC consortium, are listed in hPSC Reg https://hpscreg.eu/
and available through EBiSC https://ebisc.org/. They are derived from
skin fibroblasts of healthy donors. The reprogramming method was
non-integrating with Sendai virus (Cytotune Reprogramming Kit,
Thermo Fisher, cat# A16517and A13780-01 respectively).
Cell line 802#7 was derived from skin fibroblasts collected at the
University of Lübeck. Reprogramming method was non-integrating
using episomal vectors.
Cell line Sex Clinical status
802#7 F healthy
SFC856-03-04 (STBCi063-A) F healthy
SFC840-03-05 (STBCi026-C) F healthy
hiPSCs were maintained in StemMACSTM iPS-Brew XF with supplement
(Miltenyi, cat #130-104-368) on Matrigel coated plates (Corning, cat#
354277) and EDTA is used for routine passage (Beers et al., 2012).
For testing in silico designed sgRNAs we used HEK 293T cells ex-
pressing S. pyogenes Cas9 under control of a Tetracycline inducible
promoter.
2.2. GuideRNA design and testing by T7-Endonuclease assay
The sgRNAs were designed in silico via the CRISPR Design Tool
http://crispr.mit.edu/. A total of four sgRNAs were selected and tested
in vitro by T7 Endonuclease Assay. All sgRNAs were designed in order
to target the region of the stop codon of the TH-gene. NGG triplets
around the stop codon where specifically selected for the design.
Four different sgRNAs were tested (see key resource table for se-
quence). The sgRNAs were cloned into a LV-FU-U6-sg-bb vector.
300,000 HEK 293T Cas9 cells were plated for transfection and Cas9
expression induced with 10 µg/ml Tetracycline. The following day, cells
were transfected with 1 µg sgRNA-carrying plasmid using
Lipofectamine LTX reagent (ThermoFisher, cat# 15338100).
Cells were kept in the same media for at least 72 h. Then cells were
lysed for gDNA extraction with QIAamp® DNA Blood Mini Kit (Qiagen,
cat# 51104).
The region around the cutting site of Cas9 was amplified with Q5®
High-Fidelity polymerase (New England Biolabs, M0492S). Primers
were designed 400 bp upstream and 1000 bp downstream of the cutting
site.
Primers
Fw (5′−3′) GGCTTAGGGATATGGTCAAGG
Rv (5′−3′) TGTTGGGTGCTCTCTCTGGA
For T7 Endonuclease assay, 200 ng of purified PCR reaction was
used for heteroduplex formation.
Heteroduplex formation in the Thermocycler using the following
conditions.
Initial Denaturation 95 °C 5 min
Annealing 95–85 °C −2 °C/second
85–25 °C −0.1 °C/s
Hold 4 °C ∞
To the annealed product, 1 µl of T7 Endonuclease (New England
Biolabs, BM0302L) was added and the mixture was incubated for
15min at 37 °C.
Reaction was stopped by adding 1.5 µl of 0.25M EDTA
(ThermoFisher, cat# 15575020).
To analyse the fragmented PCR the whole reaction was loaded onto
a 2% Agarose (BioRad, 1613101) gel with a loading buffer without
bromophenol blue. For DNA visualization GelStar™ Nucleic Acid Gel
Stain (Lonza, LO50535) was used.
The gel image was acquired using a ChemiDoc™ Imaging Systems
and analysed using ImageLab to measure the integrated intensity of not
cleaved and cleaved bands (see Fig S1A)
For each lane the fraction of the PCR product cleaved (fcut) was
calculated using the following formula (Ran et al., 2013):
fcut= (b+ c)/(a+ b+ c), where a is the integrated intensity of the
undigested PCR product and b and c are the integrated intensities of
each cleavage product.
The percentage of Indel formation was estimated with this formula:= ×Indel% 100 (1 (1 fcut) )
sgRNA4 was identified as the most efficient. Sequence is: 5′ GACGCC
GTGCACCTAGCCAA 3′, protospacer adjacent motif (PAM) sequence is
TGG. The oligonucleotides for this sgRNA were cloned into the ex-
pression vector pX459V2.0-eSpCas9(1.1) (Addgene #108292)
(Ran et al., 2013).
2.3. Plasmid construction for HDR
The donor sequence was cloned into the commercially available
Zero Blunt™ TOPO™ PCR Cloning vector (ThermoFisher, cat# 450031).
For homology arms, the sequences for left and right arm were amplified
from genomic DNA (see key resource table for primer sequence),
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annealed to each other and subsequently inserted bluntly into the
vector. T2A, eGFP, loxP-EF1a-Blast-loxP was cloned into the vector
between the two 800 bp homology arms into XbaI (New England
Biolabs, cat# R0145S) and XhoI (New England Biolabs, cat# R0146S)
restriction sites (see supplementary information for FASTA sequence of
TH Donor). The Stop codon of TH gene was in this way cut out of the
sequence.
2.4. Electroporation of hiPSCs
For gene editing at the TH locus, a Neon electroporation system was
used (ThermoFisher, cat# MPK5000), using methodology adapted for
gene editing hiPSC (Buchrieser et al., 2017; Flynn et al., 2015). 3× 106
hiPSCs of each cell line were transfected by electroporation (1250 V,
20ms pulse width, 1pulse) in a 100µL tip with 15 µg total DNA (3.11 µg
sgRNA plasmid and 11.35 Donor plasmid). All plasmids used for elec-
troporation were prepared using an endotoxin free MidiPrep Kit
(ThermoFisher, cat# K210004). After electroporation, the cells were
plated at high density (4×105 cells/cm2) in StemMACS medium
without Pen/Strep containing 10 µM Rock-Inhibitor (Miltenyi, cat#
130–104–169). 24 h after electroporation Puromycin (SantaCruz Bio-
technology, cat# sc-108071A) selection was started with 0.5 µg/ml for
48 h. After another 24 h without Puromycin cells were replated onto
MEF cells for clonal selection (see supplementary information) and
some were lysed for gDNA extraction for HDR screen.
2.5. Digital droplet PCR homologous directed repair screening
For homologous directed repair (HDR) screening, gDNA from cells
96 h after electroporation was analysed. gDNA was extracted with
QIAamp® DNA Blood Mini Kit (Qiagen, cat# 51104). Two hydrolysis
probes were used for HDR detection (FAM) (Fig 1) and multiplexed
with a standard reference gene hydrolysis probe (RPP30, HEX, BioRad
cat# 10031243). For reaction setup, ddPCR Supermix for probes was
used (BioRad, cat# 11969064001). For droplet formation Droplet
Generation Oil for probes was used (BioRad, cat# 1863005). Droplet
formation and PCR readout was carried out in BioRad systems for
ddPCR.
For HDR screening, 130 ng of gDNA were used per reaction,
equivalent to ca. 40000 DNA copies (one human genome=3.3pg).
The assays used for HDR screen were made of the same forward and
reverse sequence but had different probe sequences (probe 1 and 2, see
key resource table).
Reaction was set up as followed.
RPP30 1.1µl
Assay 1 1.1µl
Assay 2 1.1µl
gDNA (130 ng) Variable
ddPCR™ Supermix for Probes (No dUTP) 11µl
H2O Up to 22µl
A positive control was included in the beginning to assess assay
quality. Positive control were non-transfected samples spiked with
custom gBlocks® (double stranded synthetic DNA fragments) from IDT®
identical to the sequence to be amplified from genomic DNA. gBlocks
were used at a 10000-fold dilution from stock and gDNA from non-
transfected samples at the same concentrations as transfected samples.
Droplet formation was performed as indicated by manufacturer.
PCR run
After PCR amplification, the plate was analysed in the QX200
Droplet Reader. Experiment Type was “ABS” (absolute quantitation)
and fluorescence was read in FAM/HEX channels. Data was analysed
using QuantaSoftTM software from BioRad. Amplitude threshold in
Channel 1 and 2 was set individually for each channel and each probe
combination. Also, amplitude threshold variation was possible between
separately run plates.
After HDR screen, iPSCs were plated for clonal selection and
screened for signal enrichment (see supplementary information for
procedures). Identified clones were expanded and underwent further
quality check by sequencing before continuing with Fluorescent-in-situ-
hybridization.
2.6. Fluorescent-in-situ-hybridization (FISH)
For TH-FISH probe construction, an additional 2000 bp sequence
homologue to the genomic sequence of TH was cloned upstream of the
left homology arm, resulting in a total of 5000 bp of hybridization se-
quence. The TH-FISH probe was labelled with Cy3-dUTP (GE
Healthcare, cat# PA13101) by nick-translation (Muller et al., 2007).
Plasmid probe (2 µg) Variable
10x Polymerase I Buffer 5µl
DNase I 1µl
DNA Polymerase I 1µl
dNTP mix without dTTP (0.2 mM each of dATP, dCTP, dGTP) 5µl
100 µM Cy3® dUTP Mix 2µl
H2O To 50µl
Reaction was incubated for 90min at 15 °C
To facilitate identification of the target chromosome, in some FISH
experiments the TH-Plasmid was co-hybridized with a DOP-PCR la-
belled chromosome 11 specific painting probe (Muller et al., 2007).
Per FISH experiment, 500 ng Cy3-labeled TH-plasmid probe DNA,
200 ng Alexa488-labeled chromosome 11 paint probe, 1 µg salmon
sperm DNA (ThermoFisher, cat# 15632011) and 10 µg human cot-1
DNA (Roche, cat# 11581074001) were mixed and ethanol precipitated
for 30min at −20 °C. The mix was centrifuged at 30,000 g for 15min
and then resuspended in 1.5 µl H20 and 3.5 µl LSI hybridization buffer
(Abbott Molecular, cat# 30-804826).
To obtain chromosome preparations for FISH, cultured cells were
incubated in Colcemide (Gibco, cat# 15210-040) solution for 4 h, fol-
lowed by hypotonic treatment in 0.075M KCl for 20min at 37 °C,
fixation with Carnoy solution (3:1 v/v methanol/acetic acid) and
spreading on a wet microscopic slide with a plastic transfer pipette.
After air-drying, the slide with the chromosome preparation was de-
hydrated in ascending ethanol concentrations (80%, 90% and 100%)
for 3min each, followed by incubation overnight on a heating plate at
50 °C.
Prior to hybridization, the FISH probes were denatured at 75 °C for
7min. The probes were then pipetted onto the microscopic slide
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Fig. 1. Generation of hiPSC knock-in lines with CRISPR/Cas9. (A) Schematic representation of the donor construct for homologous recombination at human TH
locus. (B) Scheme of primer-probe position for ddPCR HDR screen (DSB, double strand break). (C) Raw droplet data of ddPCR measured for three different cell lines
four days after electroporation with CRISPR plasmids. For each graph, a non-transfected control sample is shown on the left side, positive events detected for HDR
sequence on the right side. Yellow lines indicate separation between sample reads. Blue dots represent positive droplets. (D) Raw droplet data of ddPCR measured for
four cell clones selected showing dramatic increase in positive droplet count for HDR sequence after single clone selection. Yellow lines indicate separation between
sample reads. Blue dots represent positive droplets. 992-9F and 992-9B are derived from 802#7 parental line, 994-12C from SFC 856-03-04 and 1003-11F from SFC
840-03-04. (E) Representative FISH image after in situ hybridization of the plasmid cloned TH donor construct (red) together with a chromosome 11 specific paint
probe (green) to metaphase chromosomes (blue) of the successfully engineered clone 992-9B. Arrow points to the TH hybridization signal near the terminal end of
the short arm of chromosome 11 (11p15.3), the chromosomal position of human TH gene (inset: display of split colour channels of the chromosome 11, highlighting
the transgene insert).
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containing the metaphase spreads, covered with a glass cover slip and
sealed using rubber cement. Slide denaturation and hybridization were
carried out in a programmable temperature controlled slide processing
system (HYBrite, Abbott Molecular) at 75 °C for 2min and at 37 °C ON,
respectively. Next, the cover slip was removed and slides were in-
cubated at 75 °C in 0.4X SSC Tween®20 0.3% (pH 7) for 2min. After
that, they were washed in 4X SSC Tween®20 0.1% (pH 7) and finally
mounted in Vectashield mounting medium with DAPI (Vector
Laboratories, cat# H-1200) under a cover slip. Fluorescence micro-
scopy, image capture and analysis were performed using a Zeiss©
Axioplan2 epifluorescence microscope controlled by an ISIS FISH
Imaging System (Metasystems).
2.7. In vitro differentiation of DA neurons
For differentiation according to (Zhang et al., 2014), cells were
plated on day 2 on Matrigel coated dishes. hiPSCs were detached with
TrypLE as described earlier and plated as a single cell suspension at a
density of 35,000 cells/cm2 in StemMACS medium with 10 µM Rock-
Inhibitor Y-27632. 24 h after plating, confluency was assessed micro-
scopically. Differentiation was started at a confluency of about 50%,
which was noted as Day 0.
For the differentiation, three media were needed. The media com-
position is listed in Table 1.
Medium was changed daily from Day 0 to Day 20:
On day 0 cells were fed with medium N1 supplemented with 10 μM
SB431542 (SB; Miltenyi, cat# 130-105-336) and 100 nM LDN-193189
(LDN; Miltenyi, cat# 130-103-925).
On day 1 and 2 cells were fed with medium N1 supplemented with
10 μM SB, 100 nM LDN, 0.25 μM Smoothened agonist (SAG;
Calbiochem, cat# 566660-1MG), 2 μM purmorphamine (Pu; Miltenyi,
cat# 130-104-465), and 50 ng/ml fibroblast growth factor 8b(FGF8b;
Miltenyi, cat# 130-095-731).
On day 3 and 4 cells were fed with medium N1 supplemented with
10 μM SB, 100 nM LDN, 0.25 μM SAG, 2 μM Pu, 50 ng/ml FGF8b, and
3 μM CHIR99021 (CH; Miltenyi, cat# 130-103-926).
On day 5 and 6 cells were fed with medium of 75% N1 and 25% N2
supplemented with 100 nM LDN, 0.25 μM SAG, 2 μM Pu, 50 ng/ml
FGF8b, and 3 μM CH.
On day 7 and 8 cells were fed with medium of 50% N1 and 50% N2
supplemented with 100 nM LDN and 3 μM CH.
On day 9 were fed with medium of 25% N1 and 75% N2 supple-
mented with 100 nM LDN and 3 μM CH.
On day 10 cells were washed once with PBS w/o Calcium and
Magnesium and then detached with Accutase (ThermoFisher, cat#
A1110501) (e.g. 1 ml per well of a 6-well plate). Accutase was added at
room temperature and cells were incubated for 5min at 37 °C in the
incubator. After the incubation, the plate was tapped until cells started
detaching. Cells were diluted 10x with PBS and transferred to a cen-
trifuge tube and spun for 3min at 300 g. After that, cells were re-
suspended in day 10 medium (identical to day 9 medium) supple-
mented with 10 µM Rock-Inhibitor and replated onto a freshly coated
Matrigel dish in ratio 1:1.
On day 11 and 12 cells were fed with medium NB-B27 supple-
mented with 3 μM CH, 10 ng/ml brain derived growth factor (BDNF;
Miltenyi, cat# 130-096-285), 10 ng/ml glial derived growth factor
(GDNF; Miltenyi, cat# 130-096-290), 1 ng/ml tumor growth factor 3
(TGF3; Miltenyi, cat# 130-094-007), 0.2mM ascorbic acid (AA; Sigma
Aldrich, cat# A7506-25 G) and 0.1mM cAMP (Enzo Life Sciences, cat#
BML-CN125-0100).
From day 13 to day 20 cells were fed daily with medium NB-B27
supplemented with 10 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF3,
0.2 mM AA and 0.1mM cAMP.
At day 20 cells were detached and centrifuged as described for day
10. After that, cells were resuspended in day 20 medium supplemented
with 10 µM Rock-Inhibitor and replated onto a freshly coated Matrigel
dishes at a density of 250,000 cells/cm2. Cells were kept in these wells
for terminal maturation and fed with day 20 medium every other day.
Once a week, medium was supplemented with 10 µg/ml Laminin
(Sigma Aldrich, cat# 11243217001).
2.8. Gene expression analysis
For gene expression analysis, RNA was extracted with the RNeasy
Mini Kit (Qiagen, cat# 74104) or with RNeasy Plus Micro Kit (Qiagen,
cat# 74034) for the RNA extraction from FACS sorted cells, quantified
with Nanodrop and RNA integrity was confirmed using Experion™
Automated Electrophoresis System (Biorad, cat#7007103). RNA was
retrotranscribed with SuperScript VILO cDNA Synthesis Kit (Thermo
Fisher, cat# 11754050). For the quantification of pluripotency genes
(Sox2, Oct3/4, nanog, Gdf3) and for TH expression levels during dif-
ferentiation 5 ng of cDNA were used. cDNA was amplified using All-in-
OneSYBR® Green qPCR Mix (GeneCopoeia) on CFX96 Real-Time PCR
Detection System (BioRad). ddPCR was carried out using 2 ng of cDNA
(corresponding to RNA quantity). For detection of eGFP (FAM;
ThermoFisher, cat# Mr04097229_mr), TH (HEX; BioRad, cat#
dHsaCPE5192176) and b-actin (FAM; ThermoFisher, cat#
Hs01060665_g1) hydrolysis probe based gene expression assays were
used. For reaction setup, ddPCR Supermix for Probes (Biorad) was used.
Reaction was performed according to standard procedures suggested by
manufacturer.
2.9. Immunocytochemistry and confocal imaging
Immunocytochemistry was performed on cells at different points of
differentiation. On day 25or day 35 in vitro, cells were fixed for co-
staining of TH and eGFP. For fixing, cells were washed carefully once
with PBS w/o Calcium and Magnesium (ThermoFisher, cat# 10010015)
Table. 1
Media for dopaminergic differentiation.
Medium N1 100ml Medium N2 100ml Medium NB-B27 100ml
DMEM, high glucose, GlutaMAX™ (ThermoFisher,
cat# 31966021)
83ml DMEM, high glucose, GlutaMAX™ 98ml Neurobasal (ThermoFisher, cat# 21103049) 96ml
KOSR 15ml N-2 Supplement (100X) (ThermoFisher,
cat# 17502048)
1ml B-27™ Supplement (50X) with Vitamin A
(ThermoFisher, cat# 17504001)
2ml
NEAA 1ml Pen/Strep 1ml GlutaMax 1ml
Pen/Strep 1ml Pen/Strep 1ml
50Mm
β-mercaptoethanol
20µl
Table 2
Antibody combinations and dilutions used for co-staining.
Epitope Host Dilution
α TH mouse 1:500 (Millipore, cat# MAB318)
α eGFP rabbit 1:1000 (ThermoFisher, cat# A11122)
α MAP2 chicken 1:5000 (abcam, cat# ab5392)
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and then fixed with 4% Paraformaldehyde (Sigma Aldrich, cat# P6148)
for 15min at RT. After fixing, cells were washed three times with PBS.
Cells were permeabilized for 5min at RT in PBS with 0.5% Triton
(Sigma Aldrich, cat# T8787) on a shaker. Then, cells were blocked in
PBS+5% donkey serum (Sigma Aldrich, cat# D9663) for 1 h at RT on
a shaker. After blocking, fixed cells were incubated in primary antibody
solution (antibodies diluted in PBS+2% donkey serum+0.2%
Triton). See Table 2 for detailed antibodies combination used.
The primary antibody incubation was carried out ON at 4 °C on a
shaker.
Cells were washed three times with PBS and incubated in secondary
antibody solution (PBS+2% donkey serum+0.2% Triton) for 3 h at
RT. See Table 3 for detailed secondary antibody combinations and di-
lutions.
After the secondary antibody incubation, cells were washed again
three times with PBS. In the last PBS wash, NucBlue® Fixed Cell
ReadyProbes® Reagent (ThermoFisher, cat# R37606) was added to
stain cell nuclei. After washing, cover slips were mounted in mounting
medium (Dako, cat# S3023) on a microscope slide and sealed with nail
polish.
Images of immunostained hiPSCs were acquired with Leica TCS SP8
laser scanning confocal microscope equipped with a white light laser
and accusto-optical beam slitters (AOBS) tuned for NucBlue®, AF488,
AF555 and AF647.
Pluripotency markers were detected using Pluripotent Stem Cell 4-
Marker Immunocytochemistry Kit (Thermo Fisher Scientific) following
the manufacturer's instructions. Briefly, after fixation in 4% PFA, cells
were permeabilized, blocked and incubated with primary antibody
overnight, followed by incubation with the fluorescent antibody.
2.10. Fluorescence – activated cell sorting (FACS)
On day 25 of differentiation, cells were dissociated to a single cell
suspension with Accutase as described before and pelleted at 300 g for
3min. Cells were stained with LIVE/DEAD™ Fixable Near-IR Dead Cell
Stain Kit (ThermoFisher, cat# L10119) according to manufacturer's
instructions. Then cells were re-suspended in sorting buffer (PBS
without Ca2++/Mg2++, Biowest, cat# L0615; 2.5% Horse Serum,
Thermofisher, cat# 16050130; 0.4% Glucose, SigmaAldrich, cat#
G7021; 5mM EDTA, SigmaAldrich, cat# EDS; DNAse I, 50 µg/ml,
Qiagen, cat# 15200) and filtered through a 35 µm cell filter (BD
Bioscience, cat# 340626) to ensure a single cell suspension. Briefly,
cells were first gated based on forward scatter and side scatter plot,
doublets and dead cells were excluded and eGFP-positive cells were
detected in the green fluorescence channel. Cell sorting was performed
by FACS Aria III (BD Bioscience) using a ceramic nozzle of size 100 µm
and cells were sorted directly into tubes containing lysis buffer (RLT,
Qiagen) at 4 °C.
2.11. Quantification and statistical analysis
For ddPCR Data analysis, QuantaSoft Software from Biorad was
used. Flow cytometry data was analysed using FACS Diva Software and
FlowJo, Version 10.
GraphPad Prism 6 (GraphPad Software, La Jolla, CA) software was
used for statistical analysis. One-way ANOVA with Bonferroni's
multiple comparison test. Unpaired two-tailed t-test with Mann-
Whitney test for parametric comparison. D'Agostino Pearson omnibus
normality test and Spearman correlation for correlation coefficient.
Values are indicated in figures as *p< 0.05, **p< 0.01, ***p< 0.001,
****p < 0.0001.
3. Results
3.1. Generation of knock-in hiPSC lines with CRISPR/Cas9 technology
We developed a CRISPR/Cas9 strategy to engineer three different
hiPSC lines (802#7, 856-03-04 and 840-03-05) at the TH locus. First,
we designed four different single guide RNAs (sgRNAs) in silico using
the online CRISPR Design Tool (http://crispr.mit.edu/; (Ran et al.,
2013)). We chose sgRNAs targeting sequences near the stop codon of
the TH gene and based on their inverse likelihood for creating off-target
mutations. Specifically, the NGG triplets near the stop codon of the TH
gene were targeted for the sequence design. To single out one sgRNA,
the efficiency of each candidate was tested in vitro using HEK 293T
cells and performing a T7 Endonuclease assay (Fig. S1A). In order to
faithfully mark TH expression, we constructed a donor plasmid to en-
gineer the TH locus at the stop codon. We aimed to obtain a fluorescent
protein expression system under the control of the endogenous pro-
moter. To this purpose, the donor plasmid contained the following in-
sert sequence: a T2A peptide sequence allowing ribosome skipping after
TH translation, the eGFP coding gene and a Blasticidine resistance
cassette with EF1a core promoter sequence flanked by loxP sites. The
insert sequence was flanked by two human TH gene homology arms of
approximately 800 bp in length (Fig. 1A). Importantly, the stop codon
was eliminated from the TH gene homologous sequence in order to get
uninterrupted expression of TH, T2A and eGFP. We electroporated
hiPSCs with the donor plasmid, together with an expression vector
carrying an enhanced version of S.pyogenes Cas9 and the chimeric
sgRNA (Addgene plasmid PX459 V2.0; # 62988). We obtained single
hiPSC clones by plating cells at low density on mouse embryonic fi-
broblast (MEF) feeder cells (see Methods). After one week, single clones
were picked up and transferred to a Matrigel coated 96-well plate and
amplified in order to obtain three replica plates (Fig. S2A).
3.2. Screening of recombination events using ddPCR
To identify successful homologous recombination (HDR) events, we
developed a novel ddPCR assay that allows screening of the transfected
cell pool as early as four days after electroporation. The assay consisted
of two primer-probe sets, where primers were identical for both sets but
probes had different sequences and were both marked with FAM
fluorophore. The forward primer was set upstream from the starting
point of the homology arm region to avoid detection of signal from
leftover plasmid after cell electroporation. The reverse primer was de-
signed on the T2A peptide sequence (Fig 1B). Therefore, only on-target
HDR events could be detected with this ddPCR strategy. We optimized
annealing and extension temperatures using gBlock® fragments, con-
taining the sequence of the target amplicon, that were spiked in with
wild-type (WT) genomic DNA. Reactions were multiplexed with a HEX
probe for RPP30 (Ribonuclease P protein subunit p30 Ribonuclease P
protein subunit p30), which was used as a housekeeping gene in order
to be able to quantitate the abundance of the HDR sequence. The op-
timized ddPCR allowed a quantitative readout of engineering efficiency
with a high sensitivity four days after transfection (Fig. 1C). We de-
tected recombination events in all three cell lines and were able to
detect events as rare in abundance as 0.37% (Fig. S1B). We quantified
an absolute difference of efficiency in three cell lines. HDR efficiency
four days after electroporation was of 0.37%, 0.64% and 0.66% for the
hiPSC lines 802#7, 856-03-04 and 840-03-05, respectively.
Table 3
Secondary antibody combinations and dilutions used for respective primary
antibody.
Epitope Host Fluorophore Dilution
α rabbit donkey AF 488 1:1000 (ThermoFisher, cat# A-21206)
α mouse donkey AF 555 1:1000 (ThermoFisher, cat# A-31570)
α chicken donkey AF 647 1:500 (Millipore, cat# AP194SA6)
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3.3. Clonal selection and characterization
After identification of positive HDR events in the cell pool, we se-
lected single hiPSC clones by plating the cell pool at a low density on a
MEF feeder layer. After one week of culture on MEF feeder cells, single
hiPSC clones were hand-picked and transferred to a Matrigel coated 96-
well plate. The 96-well plates were expanded and triplicated in order to
obtain three identical replica plates (Fig. S2A). One replica plate was
used for genomic DNA extraction and ddPCR screening of single clones.
We pooled together columns of a 96-well plate in a first run, to reduce
the number of ddPCR reactions. Upon positive signal detection, each
well of one column was screened individually to identify the positive
clone (Fig. S2B). Signal enrichment could be observed from several
clones from all cell lines (Fig. 1D) confirming a clonal identity. Suc-
cessfully identified clones were singled out and then sequenced at the
TH locus to confirm the accuracy of the integrated sequence and to
confirm the intactness of the non-engineered allele. Eight out of 9 se-
lected clones were correctly engineered with the WT allele remaining
unaffected. Only a single clone showed large Indel regions on the WT
allele and was discarded. As an additional quality assessment, we per-
formed FISH with a probe for the insert and homology arm sequence.
This was in order to validate the correct chromosomal position of the
insert and to exclude off-target integrations of the plasmid sequence
elsewhere in the genome. We observed specific hybridization near the
p-arm telomere of chromosome 11 (Fig. 1E), corresponding with the
chromosomal mapping position of the human TH gene in band 11p15.5,
genomic coordinates chr11:2,163,928-2,174,080 (GRCh38). Other hy-
bridization signals were not detected confirming the absence of random
integrations of the donor plasmid. We then confirmed that control and
edited hiPSC lines correctly maintained their pluripotency status. For
this, we immunostained hiPSCs for the established pluripotency mar-
kers TRA-1-60, OCT3-4, SSEA4, SOX2. We observed comparable im-
munosignals in WT and TH-eGFP hiPSCs, which display robust ex-
pression of all markers (Fig. S3). To further confirm the pluripotency
status of cells, we quantified gene expression of Sox2, Oct3/4, Nanog
and Gdf3 via qRT-PCR. The mRNA levels of these markers were un-
detectable in control fibroblasts and were potently elevated in WT and
edited hiPSC lines (Fig. S3).
3.4. TH and eGFP are co-expressed and endogenous eGFP is detectable by
flow cytometry
In order to detect eGFP expression under the control of the TH
promoter, we adapted an efficient differentiation protocol for DA
neurons from hiPSCs (Zhang et al., 2014). We measured TH gene ex-
pression in WT cells using qRT-PCR to assess the earliest time point at
which TH-eGFP co-expression could be detectable and to compare
mRNA levels between WT and TH-eGFP cells. We observed a con-
siderable increase in TH gene expression at day 25 in vitro (Fig. 2A),
consistent with previous observations (Fedele et al., 2017). In addition,
TH gene expression did not quantitively differ between WT and edited
neurons (Fig. 2A). Differentiated WT and TH-eGFP neurons were also
immunostained for TH to confirm a similar differentiation capacity
(Fig. 2B). Next, we tested and directly compared the parallel expression
of TH and eGFP in differentiated knock-in reporter lines into DA neu-
rons and extracted RNA at two different time points, day 25 and day 35,
when we (Fig. 2A) and others (Adil et al., 2017) show initial (day 25)
and more robust (day 35) TH expression. After cDNA production by
retrotranscription, we ran ddPCR with two custom assays for TH and
eGFP (see Key resource table) to identify copy numbers of cDNA for
both genes. Using QuantaSoft software we could determine a ratio of
eGFP copy number versus TH copy number at day 25 and at day 35
(Fig. 3A) in TH-eGFP clones. Correctly, we did not detect any eGFP
mRNA in non-engineered cells. In addition, the absolute values of cDNA
copies/ng for eGFP resulted half that of TH (Fig. 3B), consistent with
successful gene editing on a single allele. A significant correlation be-
tween TH and eGFP copy number/clone was determined (Spearman
correlation coefficient= 0.952, P<0.0001, n=33). We were thus able
to quantitatively confirm the heterozygous integration of eGFP gene
under TH promoter control, confirming observations with the FISH
assay, and proving that genetically the reporter system is working ac-
curately.
At day 25, we detached cells for fluorescence – activated cell sorting
(FACS) in order to isolate TH-eGFP reporter cells. Non-engineered
802#7 cells served as a negative control to draw gates in the FITC
channel. When analysing TH-eGFP reporter cells, we detected a fraction
of cells that could be clearly distinguished from the non-fluorescent
population of cells. In dot plots representing SSC-A against green
Fig. 2. Differentiation of hiPSCs into DA neurons. (A) Time course of TH gene expression in neurons derived from WT hiPSCs (clone 802#7) and TH-eGFP reporter
cells (clone 100311F) at in vitro day 25 and day 35. Data shown as fold increase over beta-actin normalized to hiPSCs (mean ± SEM). (B) Immunostaining of TH in
WT hiPSCs and in TH-eGFP reporter line at two different time points. TH staining is compared between WT hiPSCs and TH-eGFP hiPSCs at in vitro day 25 and day 35
(scale bar= 100 µm).
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Fig. 3. TH and eGFP co-expression. (A) Box whiskers plot showing ratio of expression profile of eGFP and TH at day 25 in vitro and day 35 in vitro. TH-eGFP knock-in
clones are compared to WT cell clones. Gene expression was measured with ddPCR. Mean values from 4 different eGFP clones and two WT clones from 5 independent
differentiations are shown. (B) Scatter plot showing copies/ng of cDNA detected with ddPCR for eGFP and TH at day 25 in vitro. Values are single data points from 4
different eGFP clones and two WT clones from 5 independent differentiations (mean ± SEM). (C) Scatter plot showing copies/ng of cDNA detected with ddPCR for
eGFP and TH at day 35 in vitro. Values are single data points from 4 different eGFP clones and two WT clones from 5 independent differentiations (mean ± SEM). (D)
Representative FACS plots of TH-eGFP neurons and control cell line neurons at day 25. Control cell line neurons were used as negative control to draw gates. (E) Plot
showing ratio of expression profile of TH of FACS sorted cells from TH-eGFP reporter neurons, FACS-sorted eGFP-positive and eGFP-negative neurons. TH gene
expression was measured with ddPCR, normalized to b-actin and expressed as fractional abundance. Mean values from n=3.
Fig. 4. TH and eGFP immunostaining. (A) Co-immunostaining of TH, eGFP and MAP-2 in TH-eGFP knock-in (clone 100311F) neurons at day 25 in vitro (scale
bar= 100 µm). (B) Co-immunostaining of TH, eGFP and MAP-2 in WT (line 802#7) neurons at day 25 in vitro (scale bar= 100 µm).
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fluorescence (FITC), the percentage of fluorescent cells was quantified
as 3.3% (Fig. 3D). We then analysed TH mRNA expression levels in
FACS-purified eGFP-positive and eGFP-negative cells at day 25 of dif-
ferentiation (a mid-stage of DA neuron induction (Kriks et al., 2011)).
ddPCR analysis demonstrated an approximately 10-fold enrichment of
TH mRNA levels in eGFP-positive compared to eGFP-negative sorted
cells confirming that eGFP fluorescence identifies DA neurons within a
heterogenous population and our approach is specific in editing TH-
expressing DA neurons (Fig. 3E). To confirm the co-presence of TH and
eGFP, we then performed immunostaining for both proteins and sub-
sequent confocal imaging in TH-eGFP reporter cells. In line with the
combination of FACS and ddPCR TH gene expression, we observed co-
expression of TH and eGFP in differentiated DA neurons in TH-eGFP
reporter cells (Fig. 4). We detected eGFP signal at day 25 (Fig. 4A) in
neurons that were also positively stained for TH and for the neuronal
marker MAP2. The signal for eGFP was absent in neurons differentiated
from non-engineered parental hiPSCs (Fig. 4B). We were not able to
detect endogenous eGFP fluorescence on fixed cells. In addition, we
determined that 82% of TH positive cells were also co-expressing eGFP,
underlining the specificity of the TH-driven expression of the fluor-
escent tag (3 independent differentiations, 10 image fields per differ-
entiation; data not shown).
These data show that not only does the reporter mimic the expres-
sion on mRNA but also on protein level. Flow cytometry and FACS
enable quantitative analysis of the cell population at a single cell re-
solution and allows a greater sensitivity in the detection of endogenous
eGFP fluorescence signal.
4. Discussion
In this study, we report a successful strategy for the generation of a
TH-driven fluorescent reporter for DAergic neurons using CRISPR/Cas9
genome engineering in combination with ddPCR for HDR screening. We
show that this approach results in a faithful co-expression of TH and an
eGFP reporter at the single cell level. Specifically, we successfully in-
tegrated a 1500 bp-long fragment into control hiPSC lines by providing
a plasmid-based donor sequence flanked by 800 bp homologous se-
quences. A seamless integration was generated without disrupting the
open reading frame of the genes involved, producing hiPSCs expressing
a fluorescent protein tag under the control of an endogenously ex-
pressed gene, thereby creating reporter lines for DA neurons. This as-
pect is particularly relevant, as it allows targeting and identification of
this specific neuronal cell type characterized by a distinct temporal
expression pattern during differentiation. We chose an engineering
strategy that forgoes the creation of a fusion protein. In vitro differ-
entiation is a highly complex biological process and the risk of dis-
rupting this process by creating a fusion protein for one of the mole-
cular hallmarks of DA neurons with no foreseeable impact of such a
product could not be undertaken. In addition, a fusion protein would
generate a hybrid TH protein, with the possibility of altering its func-
tion and/or subcellular trafficking. Therefore we opted for a strategy
that allowed the co-expression and co-translation (Wang et al., 2015) of
both proteins independently in order to guarantee their physiological
functionality. We show here that this construct leads to a perfect
overlap of gene expression. Also, a co-presence of both proteins could
be observed in the same neuron. To facilitate the screening of en-
gineered hiPSCs, we designed a ddPCR method, which was validated
not only to detect the insertion of the fluorescent tag but also to de-
termine the correct locus of recombination. In fact, even though ad-
vancements in CRISPR/Cas9 technology led to a higher level of re-
combinant accuracy by enhanced variants of Cas9 (Kato-Inui et al.,
2018; Slaymaker et al., 2016), we could not exclude random plasmid
integration causing expression of the fluorescent tag in a TH promoter-
independent manner. We designed a ddPCR assay spanning the targeted
genomic region upstream of the homology sequence cloned and fused
with the fluorescent tag. Therefore, only after integration at the correct
genomic locus, the PCR product could be amplified allowing identifi-
cation of positively engineered clones. We optimized this technology in
order to identify even very low-abundance events of successful homo-
logous recombination. Introducing this screening as early as four days
after transfection, allowed us to estimate the number of clones to be
selected by hand, and to discard unsuccessfully transfected cell lines.
Moreover, through the ddPCR screening method we were able to de-
termine the absolute value of successfully engineered cells. This clearly
indicated that differences in engineering efficiency exist and that they
are cell line-dependent, an effect that has yet not been described, but
can clearly be reported in a quantitative manner with our method. Most
important is that applying this screening method for genome en-
gineering experiments allows us to perform a clone screening a priori,
before continuing with the manual selection of the hiPSC clones, which
is cost and work intensive and should be avoided if possible. The co-
expression of TH and eGFP is confirmation of successful genetic en-
gineering, and we addressed this using complementary methodologies.
First, we demonstrated using ddPCR that mRNA expression of both the
target gene (TH) and the reporter (eGFP) is perfectly aligned on the
basis of the homologous recombination on a single TH allele, with eGFP
mRNA being half that of TH. This proved that, at the genomic level, the
tandem of TH-T2A-eGFP is fully functional and that the eGFP expres-
sion profile mimics that of TH, thus enabling the potential selective
identification of DA neurons upon differentiation. Our ddPCR gene
expression approach first describes a method to quantify gene load of
such a gene-T2A-reporter tandem in order to validate its functionality.
We were not able to detect endogenous fluorescence for eGFP through
confocal imaging. In our study, the expression of the reporter tag is
under the control of an endogenously regulated gene, therefore quite
different from vector-based recombination systems with expression of a
gene under the control of a viral promoter (e.g. CMV) with high
abundance of the fluorescent tag. In fact, in our study the signal-to-
noise ratio between reporter tag-driven fluorescence versus auto-
fluorescence is reduced thus impairing the detection of the fluorescent
signal even by confocal microscopy. To overcome background fluores-
cence, eGFP has to be at a concentration of at least 200 nM, a protein
load two times that of MAPKKK (Snapp, 2005). An impairment in
translation using a T2A system is also possible to some extent
(Wang et al., 2015), that may reduce the protein load for eGFP further,
thus minimizing the brightness of an endogenous signal. However, we
were able to detect the fluorescent proteins with indirect labelling in
immunocytochemistry experiments. An overlapping TH-eGFP expres-
sion was observed upon differentiation into DA neurons thus con-
firming the gene expression data and the functionality of the TH-T2A-
eGFP tandem construct. The fact that endogenous eGFP fluorescence is
detectable in flow cytometry is indeed pivotal, confirming that the
detection of the endogenous fluorescence is a technical matter of in-
strument sensitivity and background fluorescence compensation. Fur-
thermore, it demonstrates that the created knock-in faithfully reports
TH expression in vitro. This is notable, as previous approaches to a TH-
reporter system failed to deliver faithful co-presence of both proteins
(Kelly et al., 2006) or were not based on endogenous gene expression
(Hedlund et al., 2007). A study was published in 2017 (Xia et al., 2017)
with a similar construct for DA neurons to that reported here, using a
red fluorescent protein, demonstrating the feasibility of using this kind
of reporter system. Compared to this previous study (Xia et al., 2017),
we detect an increased proportion of TH positive cells with our eGFP
reporter, which potentially represents a more suitable fluorophore for
flow cytometry experiments requiring a high sensitivity such as eGFP.
Indeed we demonstrate that our system is suitable for sorting enriched
TH-expressing neurons based on the (endogenous) fluorescence signal
emitted by the reporter, as proven by the increased number of TH
mRNA copies in eGFP-positive FACS-sorted neurons, compared to
eGFP-negative ones, in an extent that matches the percentage of eGFP
positive sorted cells. Thus, our approach allows the specific enrichment
of the DA neuronal cell population for molecular studies, with the
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potential to sort viable TH-expressing neurons while maintaining the
integrity of the cell membrane for functional investigations. At the same
time, it delivers the most important application of this kind of reporter
construct. Being intended to distinguish DA neurons from non-DA
neurons, we can in this manner not only discriminate a certain popu-
lation but also separate it to enrich the DA neuronal cell population in
culture. Most importantly, our approach can be applied also to cells
derived from mutation-carrying patients in order to isolate patient or
healthy control DA neurons in parallel and directly compare pheno-
types from the cell type of interest without suffering contaminations
from non-DA cells. As there is no widely accepted surface marker for DA
neurons (Lehnen et al., 2017), the availability of an endogenous
fluorescent reporter is a major step forward to producing a more
homogeneous TH-positive neuronal culture. In conclusion, our results
demonstrate that we have developed a reproducible method that fa-
cilitates the creation of knock-in cell lines in hiPSCs. We developed this
method on a DA neuron specific locus but it is applicable to any other
desired locus throughout the genome. The ddPCR method is a technique
with increasing potential to facilitate genome-editing experiments
(Miyaoka et al., 2018) and we show that its application to clonal
screening offers considerable advantages in mutation detection because
of its high sensitivity. Additionally, here we have shown that TH-eGFP
reporter system could represent a reliable method to address DA neuron
physiology, their differentiation, and their connection to disease de-
velopment. The potential to sort these cells as neuronal DAergic pre-
cursors could greatly contribute to the development of regenerative
medicine therapeutic approaches in PD.
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